AzTrials
AzTrials

StrokeNCT07336667

The Effect of Robot-Assisted Gait Training With or Without Plantar Pressure Summary Feedback: Impact on Gait Symmetry and Balance in Hemiplegic Patients

A study testing Lokomat robot assisted gait training and Plantar pressure summary feedback in people with Stroke and Hemiplegia, run by Yeonji Choi at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized, single-blind clinical trial is to learn whether a 4-week Lokomat-based gait training program with plantar pressure feedback can improve gait symmetry and balance in adult patients with chronic hemiplegic stroke. Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Stroke, Hemiplegia
What is being tested?
Lokomat robot assisted gait training and Plantar pressure summary feedback
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteSouth Korea
Study dates
5 Feb 2026to 1 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients with hemiplegia after stroke who are currently admitted to or visiting the rehabilitation therapy department of Seoul Brain Hospital in Yeongdeungpo-gu, Seoul, Republic of Korea.
  • Chronic stage after stroke onset of at least 6 months.
  • Diagnosis of unilateral hemiplegia.
  • Mini-Mental State Examination(MMSE) score ≥ 24, with ability to understand the study procedures and provide informed consent.
  • Functional Ambulation Catefories(FAC) score of 1-2(FAC 0 excluded.)
  • Ability to communicate voluntarily for participation and consent.
  • Suiable physical condition for robot-assisted gait training(RAGT) and use of Lokomat device, including body weight ≤ 135 kg and height between approximately 150 cm and 2.0 m.

Who cannot join

  • MMSE score ≤ 23, indicating difficulty understanding the study procedures or expressing informed consent.
  • History of major psychiatric disorders such as schizophrenia, major depressive disorder, or bipolar disorder.
  • Uncontrolled cardiovascular or respiratory disease that makes gait training unsafe, such as uncontrolled hypertension, significant arrhythmia, angina, or acute exacerbation of respiratory disease.
  • Orthopedic or neuromuscular conditions that prevent safe robotic gait training, including:
  • Lower limb surgery or fracture within the previous 3 months.
  • Moderate-to-severe joint contracture or severe spasticity (e.g., Modified Ashworth Scale ≥ 3).
Show all 13Show fewer
  • Clinically significant leg-length discrepancy (≥ 2 cm).
  • Severe skin infection, pressure ulcer, or other skin condition at the harness or strap contact areas that makes physical contact difficult.
  • Low back pain, dizziness, orthostatic hypotension, or other symptoms that prevent continuation of RAGT.
  • Acute or recurrent neurological events within the previous 3 months (e.g., recurrent cerebrovascular events).
  • Any other medical condition that the principal investigator judges to make participation unsafe.
  • Vulnerable Populations:
  • This study includes only adult participants and does not enroll legally vulnerable populations such as minors or pregnant women. For inpatients, potential reduction in voluntariness due to relationships with treating clinicians is minimized by obtaining consent from a non-treating researcher, allowing sufficient time for decision-making, permitting withdrawal at any time without penalty, and allowing a caregiver to be present during the consent process if desired.

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Duksoo Medical Foundation Seoul Brain Hospital

    Seoul, Seoul, 07301

Other trials in South Korea

About this study

Official title: 족저압 요약 피드백 제공 유무에 따른 로봇보조보행훈련의 효과: 편마비 환자의 보행 대칭성과 균형에 미치는 영향; The Effect of Robot-Assisted Gait Training With or Without Plantar Pressure Summary Feedback: Impact on Gait Symmetry and Balance in Hemiplegic Patients

The goal of this randomized, single-blind clinical trial is to learn whether a 4-week Lokomat-based gait training program with plantar pressure feedback can improve gait symmetry and balance in adult patients with chronic hemiplegic stroke. The main questions it aims to answer are:

Does Lokomat training with plantar pressure feedback improve spatiotemporal gait symmetry, as measured with the GAITRite system, more than Lokomat training without plantar pressure feedback? Does this intervention lead to greater improvements in balance and walking speed, assessed by the Berg Balance Scale (BBS) and the 10-Meter Walk Test (10MWT), compared with conventional Lokomat training? Researchers will compare a group receiving Lokomat training with both real-time feedback and additional summary plantar pressure feedback to a group receiving Lokomat training with real-time feedback only, to see if adding plantar pressure feedback results in superior gains in gait symmetry, balance, and walking ability.

Participants will be adult inpatients with chronic hemiplegic stroke. They will be randomly assigned to one of the two training groups and will receive Lokomat-based gait training three times per week for 30 minutes per session over four weeks. Before and after the intervention period, participants will undergo gait analysis using the GAITRite walkway and clinical assessments including the BBS and 10MWT.

Conditions
Stroke, Hemiplegia
Being tested
Lokomat robot assisted gait training, Plantar pressure summary feedback
Keywords
Chronic hemiplegic stroke, robot assisted gait training, Lokomat, GaitRite, Plantar pressure feedback
Medical subject headings
Stroke, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lokomat robot assisted gait trainingDevice

    Lokomat robot assisted gait training for 30 minutes per session, 3 times per week, for 4 weeks. Real-time(biofeedback graph) visual and auditory feedback provided by the Lokomat system is used during gait training in both groups.

  • Plantar pressure summary feedbackOther

    Experimental group, plantar pressure data are collected during each Lokomat session using instrumented insoles. After each session, session by session plantar pressure summary feed back and gait symmetry is provided to the participant to promote more symmetrical gait. The control group does not receive this plantar summary feedback.

Study groups in NCT07336667
Study groupRoleWhat they receive
Lokomat with plantar pressure summary feedbackExperimentalParticipants receive 30 minute Lokomat(robot-assisted gait training) with real-time feedback plus additional plantar pressure summary feedback. Training is provided 3 times per week for 4 weeks. Balance and gait symmetry are assessed before and after the intervention
Receives: Device: Lokomat robot assisted gait training; Other: Plantar pressure summary feedback
Real-time feedback(biofeedback program)Active comparatorParticipants receive 30 minute Lokomat(robot-assisted gait training) training with real-time feedback only. Training is provided 3 times per week for 4 weeks. Balance and gait symmetry are assessed before and after the intervention.
Receives: Device: Lokomat robot assisted gait training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in gait symmetry(GaitRite)

    Measured: Change from baseline to 4 weeks after randomization(end of intervention)

  2. Change in gait symmetry(10-meter walk test)

    Measured: Change from baseline to 4 weeks after randomization(end of intervention)

Secondary outcomes (2)
  1. Change in balance performance(Berg Balance Test)

    Measured: Change from baseline to 4 weeks after randomization(end of intervention)

  2. Change in balance performance(Timed Up and Go test)

    Measured: Change from baseline to 4 weeks after randomization(end of intervention)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2026
  2. Study start5 Feb 2026
  3. Primary completion29 Apr 2026
  4. Study completion1 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
16 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07336667
Sponsor's protocol ID
2025-08-026-003
Status last verified
Jan 2026
First submitted
11 Dec 2025
Last updated
16 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Lokomat robot assisted gait training and Plantar pressure summary feedback in people with Stroke and Hemiplegia, run by Yeonji Choi at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in gait symmetry(GaitRite) (time frame: Change from baseline to 4 weeks after randomization(end of intervention)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in